1. Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib

   • Vikram Malhi
   • Nageshwar Budha
   • Luna Musib

   Original Article 01 September 2021 Pages: 921 - 930

   

2. The use of vitamin E in preventing taxane-induced peripheral neuropathy

   • Muhammad Ali Heiba
   • Soheir Sayed Ismail
   • Khaled Abdel-Aziz Kamal

   Original Article 01 September 2021 Pages: 931 - 939

   

3. Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach

   • Ken Ogasawara
   • Rebecca N. Wood-Horrall
   • Gopal Krishna

   Original Article 03 September 2021 Pages: 941 - 952

   

4. Zileuton inhibits arachidonate-5-lipoxygenase to exert antitumor effects in preclinical cervical cancer models

   • Liling Li
   • Yifang Xiao
   • Shaoshuai Wang

   Original Article 03 September 2021 Pages: 953 - 960

   

5. Human placental extract ameliorates methotrexate-induced hepatotoxicity in rats via regulating antioxidative and anti-inflammatory responses

   • Mamdooh Ghoneum
   • Mohamed S. A. El-Gerbed

   Original Article Open access 10 September 2021 Pages: 961 - 971

   

6. Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial

   • Nora Isberner
   • Sabrina Kraus
   • Oliver Scherf-Clavel

   Original Article Open access 10 September 2021 Pages: 973 - 983

   

7. Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor

   • Yakun Chen
   • Yong Tang
   • Daotai Nie

   Original Article 15 September 2021 Pages: 985 - 996

   

8. Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission

   • Mario González-Sales
   • Nassim Djebli
   • François Mercier

   Original Article 18 September 2021 Pages: 997 - 1007

   

9. Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas

   • Elizabeth G. Gibson
   • Olivia Campagne
   • Clinton F. Stewart

   Original Article 29 September 2021 Pages: 1009 - 1020

   

10. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer

    • Zhenhuan Xiao
    • Yun Liu
    • Songzhi Wei

    Original Article 02 October 2021 Pages: 1021 - 1031

    

11. Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer

    • Hsuan-Ming Yao
    • Sarah Ruta Jones
    • Faith D. Ottery

    Original Article Open access 07 October 2021 Pages: 1033 - 1048

    

12. Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results

    • Clotilde Gaible
    • Céline Narjoz
    • Nicolas Pallet

    Short Communication 13 September 2021 Pages: 1049 - 1053

    

13. Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia

    • Hiroaki Goto
    • Yuki Yoshino
    • Shoko Goto

    Correction 18 July 2021 Pages: 1055 - 1056